Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching Enfuvirtide to Raltegravir in Suppressed HIV-1 Patients (CHEER)
NCT00529243Phase 3Completed
- Sponsor
- Kaiser Permanente
- Start
- Sep 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Kaiser Permanente. Started Sep 2007; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00529243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529243.